Equities

Neuland Laboratories Ltd

NEULANDLAB:NSI

Neuland Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)7,368.70
  • Today's Change-287.65 / -3.76%
  • Shares traded37.54k
  • 1 Year change+253.38%
  • Beta1.3219
Data delayed at least 15 minutes, as of Apr 19 2024 11:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • NEULANDLAB:NSI price reached a new 52-week high of 7,663.85 at 12:30 BST
  • NEULANDLAB:NSI price reached a new 52-week high of 7,348.45 at 13:35 BST
  • NEULANDLAB:NSI trading volume exceeds daily average by +96.60%
  • NEULANDLAB:NSI price moved over +6.03% to 7,067.20

Key statistics

Neuland Laboratories Ltd (NEULANDLAB:NSI) set a new 52-week high during Thursday's trading session when it reached 7,790.00. Over this period, the share price is up 272.15%.
52-week range
Today
1,950.00Apr 24 20237,790.00Apr 18 2024
Open7,590.05
High7,600.00
Low7,202.35
Bid7,368.70
Offer--
Previous close7,656.35
Average volume56.18k
Shares outstanding12.83m
Free float8.10m
P/E (TTM)30.98
Market cap98.23bn INR
EPS (TTM)247.14
INR
Annual div (ADY)10.00
INR
Annual div yield (ADY)0.13%
Div ex-dateJul 11 2023
Div pay-dateAug 26 2023
Data delayed at least 15 minutes, as of Apr 19 2024 11:14 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.